AIS's Health Business Daily is a daily email newsletter with strategic business stories written by senior AIS reporters, as well as quick-and-easy news bites of interest to health care business leaders. Subscribe now to get an issue delivered to your inbox every morning!
Drug Benefit News
Today’s issue is brought to you by AIS Health's Drug Benefit News, biweekly news and proven cost management strategies for health plans, PBMs, pharma companies and employers. Sign up for an $86 two-month trial subscription today.

Note: Health Business Daily will not be published Dec. 26. The next issue will be sent on Dec. 27.

December 23, 2016

Today's Featured Story

FDA Same-Day Approval of New Diabetes Therapies Should Help Payers
Reprinted from DRUG BENEFIT NEWS

When the FDA approved Novo Nordisk A/S’s Xultophy 100/3.6 (insulin degludec 100 units/mL and liraglutide 3.6 mg/mL injection) and Sanofi’s Soliqua 100/33 (insulin glargine 100 units/mL and lixisenatide injection 33 mcg/mL) on Nov. 21, those approvals came a few months after originally expected, but their timing will benefit payers.... Read Full Story


Quote of the Day

“I speak the language of insurance, but am no expert. I am, however, an expert in managing a government office that is lean, under budget, has found significant cost savings, and that gives back to the community.”

— New Castle County, Del., Sheriff Trinidad Navarro, who won November’s election to be the state’s next insurance commissioner

Click here to read the HEALTH PLAN WEEK article in which this quote appeared — "Newly Minted State Regulators Hope to Attract Competitors, Hold Down Rate Hikes" (Free for HPW subscribers; $17 for non-subscribers.)


Today's Datapoint

866,978... medical members were gained by BlueCross BlueShield of Tennessee from 2015 to 2016, an increase of almost 34%.

From THE AIS GUIDE TO BLUE CROSS AND BLUE SHIELD PLANS. (Not affiliated with the Blue Cross and Blue Shield Association or its member companies.)


Today from Washington

People on the Move

Bioniz Therapeutics, Inc. appointed Paul Frohna, M.D., Ph.D., Pharm. D., senior vice president of clinical development, a newly created position. Frohna most recently was the vice president of clinical development and translational medicine at Receptos, Inc….CytRx Corporation promoted Executive Vice President and Chief Medical Officer Daniel Levitt, M.D., Ph.D., to the newly created role of chief operating officer. Going forward, Dr. Levitt will continue to serve as CytRx's chief medical officer.


The Featured Story of the day may be accessed on the day it is transmitted without logging in to Thereafter, you may need to log in to access the Featured Story. If you haven’t yet registered on, please take a minute to create a free account now and get free access to thousands of articles, blogs and much more.

Content questions or suggestions should be directed to Executive Editor Jill Brown at If you are interested in advertising in AIS's HEALTH BUSINESS DAILY, please contact BJ Taylor at

AIS's HEALTH BUSINESS DAILY is copyrighted and protected by federal law. The re-use of its content is restricted (see below). However, you are permitted to forward this email to as many of your friends and colleagues as you wish, or better yet have them sign up for their own copy at atlantic_subscription.cfm

Copyright © 2016 Managed Markets Insight & Technology, LLC. All rights reserved. It is not permissible to include all or any portion of this content on any Web site, intranet or electronic network or in any print publication, without AIS's written permission in advance. Permission requests should be directed to

With archives of AIS's Health Business Daily, features like the News Archives, AIS Blogs and more! (Free registration required)

AISHealth  Follow AISHealth on Twitter  Follow AISHealth on Facebook  Follow AISHealth on LinkedIn



Advertise with AIS
Drug Benefit News
The AIS Guide to Blue Cross and Blue Shield Plans
Preorder AIS's Directory of Health Plans: 2017
Health Plan Facts, Trends and Data: 2016-2017